The NIH is offering a grant to support research investigating the causes, diagnosis, and impact of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in diverse populations. Emphasis is placed on understanding environmental and biological risk factors, heterogeneity among individuals with ME/CFS, and the influence on multiple body systems. Funding is available for interdisciplinary research to develop biomarkers, study organ system responses, and improve diagnosis and treatment strategies. Applicants are encouraged to propose innovative research to advance knowledge and enhance the quality of life for individuals with ME/CFS. Closing date for applications is March 5, 2023.
Opportunity ID: 326294
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-20-165 |
| Funding Opportunity Title: | Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R01 Clinical Trials Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Environment Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.113 — Environmental Health |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 13, 2020 |
| Last Updated Date: | Apr 13, 2020 |
| Original Closing Date for Applications: | Mar 05, 2023 |
| Current Closing Date for Applications: | Mar 05, 2023 |
| Archive Date: | Apr 10, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Special district governments Others (see text field entitled “Additional Information on Eligibility” for clarification) City or township governments Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities County governments Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) encourages investigator(s)-initiated applications that propose to examine the etiology, diagnosis, pathophysiology and manifestations of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in diverse groups and across the lifespan. Applications that address gaps in the understanding of the environmental and biological risk factors, the determinants of heterogeneity among individuals with ME/CFS, and the common mechanisms influencing the multiple affected body systems in ME/CFS are encouraged. The NIH is particularly interested in funding interdisciplinary research that will enhance our knowledge of disease processes and provide evidence-based solutions to improve the diagnosis, treatment, and quality of life of all persons with ME/CFS. This interdisciplinary research may include the building of scientific teams to study and develop biomarkers and/or characterize the pathophysiological response of organ systems in individuals with ME/CFS. Applicants are encouraged to propose novel and innovative research that will break new ground or extend previous discoveries toward new directions. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-20-165.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 326294 Full Announcement-PAR-20-165 -> PAR-20-165-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00260980 | May 05, 2020 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00269759 | Oct 28, 2021 | Jan 24, 2023 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00277704 | Nov 01, 2022 | Mar 05, 2023 | View |
Package 1
Mandatory forms
326294 RR_SF424_2_0-2.0.pdf
326294 PHS398_CoverPageSupplement_5_0-5.0.pdf
326294 RR_OtherProjectInfo_1_4-1.4.pdf
326294 PerformanceSite_2_0-2.0.pdf
326294 RR_KeyPersonExpanded_2_0-2.0.pdf
326294 PHS398_ResearchPlan_4_0-4.0.pdf
326294 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
326294 RR_Budget_1_4-1.4.pdf
326294 RR_SubawardBudget30_1_4-1.4.pdf
326294 PHS398_ModularBudget_1_2-1.2.pdf
326294 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
326294 RR_SF424_5_0-5.0.pdf
326294 PHS398_CoverPageSupplement_5_0-5.0.pdf
326294 RR_OtherProjectInfo_1_4-1.4.pdf
326294 PerformanceSite_4_0-4.0.pdf
326294 RR_KeyPersonExpanded_4_0-4.0.pdf
326294 PHS398_ResearchPlan_4_0-4.0.pdf
326294 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
326294 RR_Budget_3_0-3.0.pdf
326294 RR_SubawardBudget30_3_0-3.0.pdf
326294 PHS398_ModularBudget_1_2-1.2.pdf
326294 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
326294 RR_SF424_5_0-5.0.pdf
326294 PHS398_CoverPageSupplement_5_0-5.0.pdf
326294 RR_OtherProjectInfo_1_4-1.4.pdf
326294 PerformanceSite_4_0-4.0.pdf
326294 RR_KeyPersonExpanded_4_0-4.0.pdf
326294 PHS398_ResearchPlan_5_0-5.0.pdf
326294 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
326294 RR_Budget_3_0-3.0.pdf
326294 RR_SubawardBudget30_3_0-3.0.pdf
326294 PHS398_ModularBudget_1_2-1.2.pdf
326294 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
